Vuy Li, MD
Clinical Cardiac Electrophysiology · Richmond, INNPI 1629168372
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,373 of the $7,876 with a category attached, or 80.9%. 37 manufacturers reported payments, led by Abbott at 32.4% of the total. 2025 is the largest year on record at $2,531, 3.4 times the $742 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.
Across 293 payments — averaging $26.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$2K
- AstraZeneca$613
- Cardiofocus, Inc.$450
- Novartis$441
- Pfizer$352
- plus $2K from 31 others
What the payments were for
- Travel & lodging$1,50419%
- Food & beverage$6,37381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 83 | $2,551 |
| Boston Scientific | 18 | $1,501 |
| AstraZeneca | 31 | $613 |
| Cardiofocus, Inc. | 1 | $450 |
| Novartis | 28 | $441 |
| Pfizer | 24 | $352 |
| Johnson & Johnson | 18 | $289 |
| Sanofi-aventis U.S. LLC | 12 | $189 |
| Boehringer Ingelheim | 8 | $187 |
| Merck | 6 | $113 |
| E.r. Squibb & Sons, L.L.C. | 7 | $103 |
| Amgen | 6 | $96 |
| Scpharmaceuticals Inc. | 5 | $90 |
| Novo Nordisk | 4 | $88 |
| Alnylam Pharmaceuticals Inc. | 4 | $88 |
| Edwards Lifesciences | 1 | $76 |
| Medtronic | 3 | $68 |
| Impulse Dynamics (USA) Inc. | 1 | $65 |
| Amarin Pharma, Inc. | 3 | $46 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Philips North America LLC | 2 | $41 |
| Astellas Pharma US Inc | 3 | $41 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $37 |
| Bayer | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Tactile Systems Technology Inc | 2 | $30 |
| Chiesi USA, Inc. | 2 | $29 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Altathera Pharmaceuticals LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 2 | $22 |
| Abiomed | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Biosense Webster, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Cardinal Health 200 LLC | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$942
- AVEIR$555
How this compares
$7,876 in reported general payments places this provider in the 30th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 426 | $349,633 |
| XareltoRivaroxaban | 78 | $83,351 |
| EntrestoSacubitril/Valsartan | 72 | $82,818 |
| JardianceEmpagliflozin | 84 | $68,620 |
| MultaqDronedarone Hcl | 53 | $55,039 |
| FarxigaDapagliflozin Propanediol | 52 | $41,405 |
| CorlanorIvabradine Hcl | 13 | $8,088 |
| Flecainide Acetate | 129 | $3,872 |
| Metoprolol Succinate | 321 | $3,280 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 190 | $2,725 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $2,561 |
| Amiodarone Hcl | 186 | $2,240 |
| SotalolSotalol Hcl | 115 | $2,106 |
| Carvedilol | 188 | $1,387 |
| ClopidogrelClopidogrel Bisulfate | 125 | $1,115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $352 | $349,633426 claims |
| Johnson & JohnsonXarelto | $289 | $83,35178 claims |
| NovartisEntresto | $441 | $82,81872 claims |
| Boehringer IngelheimJardiance | $187 | $68,62084 claims |
| Sanofi-aventis U.S. LLCMultaq | $189 | $55,03953 claims |
| AstraZenecaFarxiga | $613 | $41,40552 claims |
| AmgenCorlanor | $96 | $8,08813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Richmond
- Xinqiang HanRichmond$32K
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.